Total buying$1.68M1 buys
OFIX
Orthofix Medical Inc.
NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$1.68M2 sells
Net open-market−$1.41kBuying minus selling
Active insiders4Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 05, 2026
Open-market transaction mix · 3 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 1 | 1 | 0 | $1.68M | $1.68M | $0 |
| Oct 2026 | 0 | 1 | 0 | $0 | $1.41k | -$1.41k |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (3)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- JL+$3.4M
- FP-$1.4k
OFIX transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
OFIXOrthofix Medical Inc. | Fisher PatrickPRES · GLR | S · sale10b5-1 detectedSEC filing ↗ | -$1.41kView disclosure → | |
OFIXOrthofix Medical Inc. | Juniper Investment Company, LLC10% | P · buyAmended filingSEC filing ↗ | $1.68MView disclosure → | |
OFIXOrthofix Medical Inc. | Juniper Investment Company, LLC10% | S · saleSEC filing ↗ | $1.68MView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Recent filing activity
Most recent 3 transactions on this page · color = transaction codeFiling detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period3transactionstxns
- S · Open-market sells · dominant2 · 67%
- P · Open-market buys1 · 33%
Activity by reported role
A joint filing can contribute to multiple roles10% owner2
GLR1
PRES1
Reported Holdings After
Separated by insider, security, and ownership type
Michas Alexis PCommon Stock, $0.10 par value per share · Indirect · By: Juniper Targeted Opportunity Fund, L.P.
3,771,216Sep 21, 2026
Bartholdson John A.Common Stock, $0.10 par value per share · Indirect · By: Juniper Targeted Opportunity Fund, L.P.
3,771,216Sep 21, 2026
Juniper Investment Company, LLCCommon Stock, $0.10 par value per share · Indirect · By: Juniper Targeted Opportunity Fund, L.P.
3,771,216Sep 21, 2026
Fisher PatrickCommon Stock · Direct
50,919Oct 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Orthofix Medical Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Orthofix Medical Inc.?
Fisher Patrick, Bartholdson John A., Juniper Investment Company, LLC, MICHAS ALEXIS P.
When was the latest reported open-market purchase?
Juniper Investment Company, LLC reported a buy on Sep 21, 2026 valued at $1.68M. Read the SEC filing.
When was the latest reported open-market sale?
Fisher Patrick reported a sale on Oct 01, 2026 valued at $1.41k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $1,416.00. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.